[THE TEST OF GENERATION OF THROMBIN IN DYNAMICS IN PATIENTS AFTER TRANSCUTANEOUS CORONARY INTERVENTION]

Insights

Patients with stable ischemic heart disease experience hypercoagulation within 1-3 days after transcutaneous coronary intervention, indicated by increased thrombin generation and reduced protein C activity, despite standard therapies.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Biochemistry

Context:

  • Ischemic heart disease (IHD) management often involves interventions like transcutaneous coronary intervention (TCI).
  • Assessing hemostasis and coagulation status post-TCI is crucial for understanding thrombotic risk.
  • The protein C system plays a key role in regulating anticoagulation.

Purpose:

  • To investigate thrombin generation and protein C anticoagulant activity in patients with stable IHD after TCI.
  • To evaluate changes in hemostasis markers in the early period following myocardial revascularization.
  • To explore correlations between thrombin generation, endothelial dysfunction, and inflammatory markers.

Summary:

  • No significant differences in thrombin generation were observed between IHD patients before TCI and healthy controls.
  • A significant increase in thrombin generation and a decrease in protein C anticoagulant activity were noted 1-3 days post-TCI.
  • Positive correlation found between endogenous thrombin potential and annexin 5 (endothelial dysfunction marker).
  • Elevated levels of C-reactive protein and fibrinogen were observed in the early post-TCI period.

Impact:

  • The study reveals a state of hypercoagulation in IHD patients during the early phase after TCI.
  • Findings suggest that standard coagulation tests may not fully capture the prothrombotic state post-intervention.
  • Highlights the need for closer monitoring of hemostatic balance and potential adjustments in therapy for IHD patients after TCI.

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.3K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.8K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
466
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.4K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
473
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
456